Viking Therapeutics, Inc. (VKTX)
NASDAQ: VKTX · Real-Time Price · USD
49.30
-2.21 (-4.29%)
Dec 3, 2024, 1:56 PM EST - Market open
Viking Therapeutics Market Cap
Viking Therapeutics has a market cap or net worth of $5.49 billion as of December 3, 2024. Its market cap has increased by 421.58% in one year.
Market Cap
5.49B
Enterprise Value
4.81B
1-Year Change
421.58%
Ranking
Category
Stock Price
$49.30
Market Cap Chart
Since April 29, 2015, Viking Therapeutics's market cap has increased from $77.50M to $5.49B, an increase of 6,988.79%. That is a compound annual growth rate of 55.85%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Dec 2, 2024 | 5.74B | 208.36% |
Dec 29, 2023 | 1.86B | 158.22% |
Dec 30, 2022 | 720.90M | 100.31% |
Dec 31, 2021 | 359.90M | -12.37% |
Dec 31, 2020 | 410.70M | -29.14% |
Dec 31, 2019 | 579.60M | 6.02% |
Dec 31, 2018 | 546.70M | 372.52% |
Dec 29, 2017 | 115.70M | 382.08% |
Dec 30, 2016 | 24.00M | -27.27% |
Dec 31, 2015 | 33.00M | -57.42% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Blueprint Medicines | 6.12B |
Cytokinetics | 6.12B |
Merit Medical Systems | 6.06B |
RadNet | 6.05B |
Corcept Therapeutics | 6.04B |
Inspire Medical Systems | 5.78B |
Krystal Biotech | 5.68B |
Grifols | 5.64B |